Trial intelligence / Profile preview

Pregabalin Phonophoresis and Nerve Flossing in Peripheral Diabetic Neuropathy

NCT07683338Completed

Sponsor
Syeda Khatoon e Jannat Welfare Foundation
Start
Feb 2026
Primary completion
Apr 2026
Countries
1
01

Overview

Randomised trial of pregabalin in diabetic peripheral neuropathy (DPN) (2 arms), sponsored by Syeda Khatoon e Jannat Welfare Foundation. Primary endpoint: Pain intensity at 12 weeks. Started Feb 2026; status: completed.

02

Drugs

pregabalin
03

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT07683338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07683338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call